OPRX
OptimizeRx Corp
Key Financials
Net Income
$5.1M
↑ 125.5%
Revenue
$109.4M
↑ 18.8%
Gross Profit
$73.6M
↑ 23.9%
Operating Income
$11.7M
↑ 185.3%
EPS (Diluted)
$0.27
↑ 124.5%
Total Assets
$176.9M
↑ 3.4%
Total Liabilities
$48.6M
↓ 10.2%
Shareholders' Equity
$128.3M
↑ 9.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G | 8/14/2026 | View on SEC |
| 10-Q | 8/13/2026 | View on SEC |
| 8-K | 8/12/2026 | View on SEC |
| SCHEDULE 13G/A | 7/29/2026 | View on SEC |
| SCHEDULE 13G | 7/22/2026 | View on SEC |
| 8-K | 6/12/2026 | View on SEC |
| 4 | 6/10/2026 | View on SEC |
| 4 | 6/10/2026 | View on SEC |
| 4 | 6/10/2026 | View on SEC |
| 4 | 6/10/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | OPRX |
| Company Name | OptimizeRx Corp |
| CIK | 1448431 |
| Sector | Services-Business Services, NEC |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 7389 |
| SIC Description | Services-Business Services, NEC |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | 248-651-6558 |